Avastin Lung Cancer Launch To Bolster Roche’s China Sales
This article was originally published in PharmAsia News
Executive Summary
Roche has launched Avastin for lung cancer in China, marking the expanded use of one of the company’s best-selling therapies globally to treat a prevalent cancer type in the country, where new product approvals have been few and far between.